title: Phase I clinical trial of donor T-helper type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant.
authors.affiliation: National Cancer Institute, Experimental Transplantation and Immunology Branch, USA.
authors.forename: D
authors.initials: D
authors.lastname: Fowler
authors.forename: J
authors.initials: J
authors.lastname: Hou
authors.forename: J
authors.initials: J
authors.lastname: Foley
authors.forename: F
authors.initials: F
authors.lastname: Hakim
authors.forename: J
authors.initials: J
authors.lastname: Odom
authors.forename: K
authors.initials: K
authors.lastname: Castro
authors.forename: C
authors.initials: C
authors.lastname: Carter
authors.forename: E
authors.initials: E
authors.lastname: Read
authors.forename: J
authors.initials: J
authors.lastname: Gea-Banacloche
authors.forename: C
authors.initials: C
authors.lastname: Kasten-Sportes
authors.forename: L
authors.initials: L
authors.lastname: Kwak
authors.forename: W
authors.initials: W
authors.lastname: Wilson
authors.forename: B
authors.initials: B
authors.lastname: Levine
authors.forename: C
authors.initials: C
authors.lastname: June
authors.forename: R
authors.initials: R
authors.lastname: Gress
authors.forename: M
authors.initials: M
authors.lastname: Bishop
mesh_terms: D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D006086:Graft vs Host Disease; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D036102:Peripheral Blood Stem Cell Transplantation; D033581:Stem Cell Transplantation / Q000379:methods*; D018418:Th2 Cells / Q000637:transplantation*; D013997:Time Factors